NEW YORK & SAN FRANCISCO, November 13, 2026--Doximity, the leading digital platform for U.S. medical professionals, NewYork-Presbyterian, Columbia University and Weill Cornell Medicine today announced that Doximity will provide clinical staff at all three academic healthcare institutions with additional AI-powered clinical decision support and scribe tools.
Doximity (NYSE:DOCS) has launched DoseCheck, an AI-powered safety layer inside its Doximity Ask clinical decision support tool. The company reports DoseCheck cuts medication dosing errors by over 99% and has reached a near zero error rate in testing. DoseCheck verifies drug dosing recommendations against FDA labeling and professional guidelines and is available free to all Doximity Ask users. The launch of DoseCheck, with its near zero dosing error record, comes as broader research uncovers...
Motley Fool Press Release.
Medical professional network Doximity (NYSE:DOCS) announced better-than-expected revenue in calendar Q3 2026 (fiscal Q2 2027), with revenue up 3.6% year on year to $174.5 million. The company expects next quarter’s revenue to be around $195.5 million, close to analysts’ consensus estimates. Its non-GAAP profit of $0.36 per share was in line with analysts’ consensus estimates.
Doximity recently introduced DoseCheck, a free drug dosing safety layer inside its Ask tool that cross checks every AI generated recommendation against FDA labeling and professional guidelines, reporting more than 99% accuracy across over 8,000 real world dosing questions. The business is tightening clinical safety controls and, through the UpToDate content integration, embedding third party evidence directly into workflows for a user base that already includes over 85% of U.S. doctors and...
Doximity (NYSE:DOCS) has rolled out DoseCheck, an AI-driven medication dosing verification feature embedded in its Doximity Ask tool. DoseCheck adds a deterministic, rule-based layer that cross checks AI dosing suggestions to help reduce medication dosing errors for patients. The company is integrating UpToDate's evidence-based clinical content into its AI clinical support tool for point of care decision support. The combination of DoseCheck and UpToDate integration aligns with broader...
Doximity (DOCS) closed the most recent trading day at $33.63, moving 1.81% from the previous trading session.
Detailed price information for Gartner Inc (IT-N) from The Globe and Mail including charting and trades.
Doximity (DOCS) closed the most recent trading day at $30.71, moving 2.51% from the previous trading session.
This is the newest page. Registered accounts read further back.